Share

March 25, 2014; 82 (12) Article

Contribution of Alzheimer disease to mortality in the United States

Bryan D. James, Sue E. Leurgans, Liesi E. Hebert, Paul A. Scherr, Kristine Yaffe, David A. Bennett
First published March 5, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000240
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1831

Share

Article Information

vol. 82 no. 12 1045-1050
DOI: 
https://doi.org/10.1212/WNL.0000000000000240
PubMed: 
24598707
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received June 12, 2013
  • Accepted in final form December 11, 2013
  • First Published March 5, 2014.

Article Versions

Copyright & Usage: 
© 2014 American Academy of Neurology

Author Disclosures

    1. Bryan D. James, PhD,
    2. Sue E. Leurgans, PhD,
    3. Liesi E. Hebert, ScD,
    4. Paul A. Scherr, PhD, ScD,
    5. Kristine Yaffe, MD and
    6. David A. Bennett, MD
  1. Bryan D. James, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Alzheimer's Association (2) Partners Healthcare

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Sue E. Leurgans, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH: P30AG010161 (ADC), core Leader and statistician, 2007-ongoing (2) NIH: RC2AG036547, statistician (3) NIH: R01 AG017917, statistician, 2008-present (4) NIH: P01 AG014449, Core leader, 2001-present (5) NIH: P01 AG009466, Core Leader, 2000-present (6) NIH: R01NS028127, statistician, 2006-present (7) NIH: R01 AG024480, statistician, 2007-present (8) NIH: R01 AG033678, statistician, 2008-present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Liesi E. Hebert, ScD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH R01NR010211 PI 2009-2012 NIH R01AG030544 biostatistician 2008-2011 NIH R01AG009966 biostatistician 2008-2010 NIH RO1AG011101 epidemiologist 2009-2011 NIH RC2AG036650 biostatistician 2009-2011

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. a contract with the Alzheimer's Association to cover some of the costs of calculating projections of numbers of people with AD in the US

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Paul A. Scherr, PhD, ScD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Rush Institute for Healthy Aging

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Employee of Centers for Disease Control and Prevention (CDC)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Kristine Yaffe, MD and
    6. Scientific Advisory Boards:

    1. -Novartis, Inc. - Pfizer -DSMB for Takeda, Inc -DSMB for NIH trials - Beeson Advisory Scientific Committee

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. -Associate Editor, 2011-, International Review of Psychiatry -Associate Editor 2012-, Journal of Gerontology: Medical Sciences

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH, NIA, NIDDK, NIMH, Department of Defense, California Department of Public Health

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Bright Focus Foundation and Alzheimer Association's

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. David A. Bennett, MD
    7. Scientific Advisory Boards:

    1. 1) Vigorous Minds, Scientific Advisory Board

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Nutricia, paid for travel to scientific meeting

    Editorial Boards:

    1. (1) Neurology, Editorial Board; (2) Current Alzheimer Research, Editorial Board; (3) Neuroepidemiology, Editorial Board

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Nutricia, Inc., (2) Eli Lilly, Inc., (3) the Gerson Lehrman Group, (4) Enzymotec Ltd., (5) Double Helix, (6) Takeda Pharmaceuticals USA, Inc

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Nutricia Inc., PI

    Research Support, Government Entities:

    1. NIH: P30AG10161, PI; R01AG15819, PI; R01AG17917, PI; R01AG36042, PI; U01AG32984, Co-I; R01AG22018, Co-I; R01AG33678, Co-I; R01AG36836, Co-I; R01AG41797, Co-I; R01AG42210, Co-I; and Illinois Department Public Health

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Rush Alzheimer's Disease Center (B.D.J., S.E.L., D.A.B.), Chicago; Departments of Internal Medicine (B.D.J.) and Neurological Sciences (S.E.L., D.A.B.), and Rush Institute on Healthy Aging (L.E.H., P.A.S.), Rush University Medical Center, Chicago, IL; Departments of Psychiatry, Neurology, and Epidemiology (K.Y.), University of California, San Francisco; and San Francisco Veterans Affairs Medical Center (K.Y.), San Francisco, CA.
  1. Correspondence to Dr. James: Bryan_James{at}rush.edu
View Full Text

Article usage

Article usage: March 2014 to July 2019

AbstractFullPdfSource
Mar 2014904833331Highwire
Apr 201426313259Highwire
May 201413971534Highwire
Jun 20146151117Highwire
Jul 20143641412Highwire
Aug 201429519Highwire
Sep 2014294412Highwire
Oct 2014357810Highwire
Nov 201428579Highwire
Dec 2014554415Highwire
Jan 20153121115Highwire
Feb 201519247Highwire
Mar 201536224Highwire
Mar 2015065pmc
Apr 201537543Highwire
Apr 201505330pmc
May 201525266Highwire
May 201503616pmc
Jun 201538613Highwire
Jun 201502713pmc
Jul 201547912Highwire
Jul 201507517pmc
Aug 201554824Highwire
Aug 201502221pmc
Sep 201552845Highwire
Sep 201504819pmc
Oct 201548341Highwire
Oct 201506721pmc
Nov 201545156Highwire
Nov 201505517pmc
Dec 201547825Highwire
Dec 201503512pmc
Jan 201640724Highwire
Jan 201602617pmc
Feb 201641123Highwire
Feb 201606111pmc
Mar 201616913Highwire
Mar 201606610pmc
Apr 201620432Highwire
Apr 201605815pmc
May 201615222Highwire
May 201604719pmc
Jun 201620287Highwire
Jun 201608420pmc
Jul 201611911Highwire
Jul 201604717pmc
Aug 201618201Highwire
Aug 20160428pmc
Sep 201615601Highwire
Sep 201605212pmc
Oct 201617023Highwire
Oct 20160375pmc
Nov 2016186711Highwire
Nov 201604015pmc
Dec 201619612Highwire
Dec 201604713pmc
Jan 201724511Highwire
Jan 20170239pmc
Feb 201722823Highwire
Feb 201703013pmc
Mar 201729912Highwire
Mar 201704112pmc
Apr 201725224Highwire
Apr 2017164348pmc
May 201727123Highwire
May 201794447pmc
Jun 201732842Highwire
Jun 2017214847pmc
Jul 201722721Highwire
Jul 2017123735pmc
Aug 201721113Highwire
Aug 2017185159pmc
Sep 201730022Highwire
Sep 2017125061pmc
Oct 201727811Highwire
Oct 2017186868pmc
Nov 201736513Highwire
Nov 2017206470pmc
Dec 201753113Highwire
Jan 201844121Highwire
Feb 201842873Highwire
Mar 201865124Highwire
Apr 201863800Highwire
Apr 2018105968pmc
May 201876027Highwire
Jun 201867155Highwire
Jun 2018174254pmc
Jul 201848600Highwire
Aug 201851612Highwire
Aug 201820120212pmc
Sep 201853143Highwire
Oct 201858873Highwire
Nov 201858111Highwire
Dec 201847313Highwire
Jan 201949763Highwire
Feb 201938876Highwire
Mar 201940847Highwire
Apr 201938736Highwire
May 201928020Highwire
Jun 201933651Highwire
Jul 201935433Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me